Literature DB >> 10400411

Cardiotoxicity of second-generation antihistamines.

D J Roberts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400411     DOI: 10.2165/00003495-199957060-00018

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  12 in total

1.  Interactions of the nonsedating antihistamine loratadine with a Kv1.5-type potassium channel cloned from human heart.

Authors:  A E Lacerda; M L Roy; E W Lewis; D Rampe
Journal:  Mol Pharmacol       Date:  1997-08       Impact factor: 4.436

Review 2.  Cardiac effects of ebastine and other antihistamines in humans.

Authors:  A J Moss; J Morganroth
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

3.  Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels.

Authors:  E Delpón; C Valenzuela; P Gay; L Franqueza; D J Snyders; J Tamargo
Journal:  Cardiovasc Res       Date:  1997-08       Impact factor: 10.787

4.  Second-generation antihistamines: a comparative review.

Authors:  J W Slater; A D Zechnich; D G Haxby
Journal:  Drugs       Date:  1999-01       Impact factor: 9.546

5.  Some observations on the cardiotoxic and drug interaction profiles of second generation antihistamines as measured in the guinea pig.

Authors:  D J Roberts; J Llenas
Journal:  Arzneimittelforschung       Date:  1996-08

6.  Cardiotoxic and drug interaction profile of the second generation antihistamines ebastine and terfenadine in an experimental animal model of torsade de pointes.

Authors:  J A Hey; M del Prado; W Kreutner; R W Egan
Journal:  Arzneimittelforschung       Date:  1996-02

7.  Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.

Authors:  J A Hey; M del Prado; J Sherwood; W Kreutner; R W Egan
Journal:  Arzneimittelforschung       Date:  1996-02

8.  The role of ketoconazole in the QTc interval prolonging effects of H1-antihistamines in a guinea-pig model of arrhythmogenicity.

Authors:  J Gras; J Llenas; J M Palacios; D J Roberts
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

Review 9.  Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

10.  Terfenadine, the first non-sedating antihistamine.

Authors:  J K Woodward; N L Munro
Journal:  Arzneimittelforschung       Date:  1982
View more
  2 in total

Review 1.  Assessing the cardiac safety of ebastine. Epilogue.

Authors:  D J Roberts
Journal:  Drug Saf       Date:  1999       Impact factor: 5.606

2.  Chemical Library Screening and Structure-Function Relationship Studies Identify Bisacodyl as a Potent and Selective Cytotoxic Agent Towards Quiescent Human Glioblastoma Tumor Stem-Like Cells.

Authors:  Maria Zeniou; Marie Fève; Samir Mameri; Jihu Dong; Christophe Salomé; Wanyin Chen; Elias A El-Habr; Fanny Bousson; Mohamadou Sy; Julie Obszynski; Alexandre Boh; Pascal Villa; Suzana Assad Kahn; Bruno Didier; Dominique Bagnard; Marie-Pierre Junier; Hervé Chneiweiss; Jacques Haiech; Marcel Hibert; Marie-Claude Kilhoffer
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.